Chemomab Therapeutics Ltd.
CMMB
$2.69
-$0.06-2.18%
NASDAQ
| 06/30/2025 | 06/30/2025 | 03/31/2025 | 06/30/2023 | 03/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -11.34% | -11.34% | -25.96% | -18.70% | -18.02% |
| Total Receivables | -13.58% | -13.58% | 384.41% | 4.72% | 116.78% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -- | -- | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 5.71% | 5.71% | 84.21% | -3.90% | 0.00% |
| Total Current Assets | -11.38% | -11.38% | -25.33% | -17.98% | -19.07% |
|
|
|||||
| Total Current Assets | -11.38% | -11.38% | -25.33% | -17.98% | -19.07% |
| Net Property, Plant & Equipment | -56.69% | -56.69% | -7.05% | -8.62% | -8.25% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -12.61% | -12.61% | -11.43% | -6.38% | -5.87% |
| Total Assets | -13.18% | -13.18% | -24.43% | -17.60% | -18.69% |
|
|
|||||
| Total Accounts Payable | -22.86% | -22.86% | -22.59% | 5.86% | 31.34% |
| Total Accrued Expenses | -36.01% | -36.01% | -33.44% | -6.32% | -5.53% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -1.74% | -6.09% | -6.50% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | -36.36% | -36.36% | -30.17% | -2.46% | 3.67% |
|
|
|||||
| Total Current Liabilities | -36.36% | -36.36% | -30.17% | -2.46% | 3.67% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -14.35% | -46.77% | -31.87% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -41.06% | -41.06% | -29.21% | -2.85% | 3.20% |
|
|
|||||
| Common Stock & APIC | 1.17% | 1.17% | 0.15% | 1.97% | 0.48% |
| Retained Earnings | -1.94% | -1.94% | -3.24% | -10.98% | -13.72% |
| Treasury Stock & Other | -- | -- | -- | 0.00% | 0.00% |
| Total Common Equity | -6.68% | -6.68% | -23.23% | -21.33% | -22.83% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -6.68% | -6.68% | -23.23% | -21.33% | -22.83% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -6.68% | -6.68% | -23.23% | -21.33% | -22.83% |
|
|
|||||